Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (631-640 of 662) with videos related to

Pageof 67
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 13, 2021
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and CanadaDidier Debieuvre, Rosalyn A Juergens, Bernard Asselain, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 22, 2024
Malignancy predictors and treatment strategies for adult intestinal intussusceptionPhilipp Reschke, Quang Anh Le Hong, Leon D Gruenewald, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
De novo design of diverse small molecule binders and sensors using Shape Complementary PseudocyclesLinna An, Meerit Said, Long Tran, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infectionYao Yu Yeo, Hsin-Yi Chen, Bokai Zhu, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Accurate <i>de novo</i> design of high-affinity protein binding macrocycles using deep learningStephen A Rettie, David Juergens, Victor Adebomi, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsFunsho J Ogunshola, Nishant K Singh, Vincent Butty, et al.
Journal of Medicinal Chemistry|May 14, 2004
Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha productionMichael P Clark, Steven K Laughlin, Matthew J Laufersweiler, et al.
Nature Chemical Biology|June 20, 2025
Accurate de novo design of high-affinity protein-binding macrocycles using deep learningStephen A Rettie, David Juergens, Victor Adebomi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through CollaborationNathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Pageof 67

Showing results (631-640 of 662) with videos related to

Sort By:
Pageof 67
Lung Cancer (Amsterdam, Netherlands)|May 13, 2021
Two-year survival with nivolumab in previously treated advanced non-small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and CanadaDidier Debieuvre, Rosalyn A Juergens, Bernard Asselain, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 22, 2024
Malignancy predictors and treatment strategies for adult intestinal intussusceptionPhilipp Reschke, Quang Anh Le Hong, Leon D Gruenewald, et al.
Biorxiv : the Preprint Server for Biology|January 8, 2024
De novo design of diverse small molecule binders and sensors using Shape Complementary PseudocyclesLinna An, Meerit Said, Long Tran, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Coordinated immune-epithelial dynamics in the nasal epithelium protect against respiratory virus infectionYao Yu Yeo, Hsin-Yi Chen, Bokai Zhu, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Accurate <i>de novo</i> design of high-affinity protein binding macrocycles using deep learningStephen A Rettie, David Juergens, Victor Adebomi, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Duration of Initial Viremia Modulates Functional Properties of HIV-specific T Cell ReceptorsFunsho J Ogunshola, Nishant K Singh, Vincent Butty, et al.
Journal of Medicinal Chemistry|May 14, 2004
Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha productionMichael P Clark, Steven K Laughlin, Matthew J Laufersweiler, et al.
Nature Chemical Biology|June 20, 2025
Accurate de novo design of high-affinity protein-binding macrocycles using deep learningStephen A Rettie, David Juergens, Victor Adebomi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2020
A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226Rosalyn A Juergens, Desiree Hao, Peter M Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Ewing Sarcoma: Current Management and Future Approaches Through CollaborationNathalie Gaspar, Douglas S Hawkins, Uta Dirksen, et al.
Pageof 67